A COMMON rheumatoid arthritis drug could hold the key to lowering blood glucose levels in patients with Type 2 diabetes, says a study. Scientists have discovered that the anti-inflammatory drug leflunomide has highly beneficial effects on diabetes sufferers.
You Can See More: Arthritis drug offers hope in diabetes fight
The following article Arthritis drug offers hope in diabetes fight is courtesy of Daily Express :: Health Feed

A COMMON rheumatoid arthritis drug could hold the key to lowering blood glucose levels in patients with Type 2 diabetes, says a study. Scientists have discovered that the anti-inflammatory drug leflunomide has highly beneficial effects on diabetes sufferers.
A COMMON rheumatoid arthritis drug could hold the key to lowering blood glucose levels in patients with Type 2 diabetes, says a study. Scientists have discovered that the anti-inflammatory drug leflunomide has highly beneficial effects on diabetes sufferers.
0 comments:
Post a Comment
Note: Only a member of this blog may post a comment.